Commercial Innovation Manager, Wayland Group
John Myhal is the Commercial Innovation Manager at Wayland Group (CSE: WAYL), a global licensed producer.
Prior to joining Wayland Group, John spent several years in the pharmaceutical sector with Johnson & Johnson Inc. His background in healthcare led him to make the professional move into cannabis, having long admired the therapeutic potential of Cannabis. His extensive experience leading the strategies of large brands like Tylenol & Swiss Chalet inspired him to be a part of the creation of this new and growing industry.
John has a degree in Business, and a minor in Psychology, from Wilfrid Laurier University, Canada.